Search Results - "Mennitto, Roberta"
-
1
Current Understanding of Urachal Adenocarcinoma and Management Strategy
Published in Current oncology reports (2020)“…Purpose of Review The aim of this review is to sum up the state of the art of urachal carcinoma (UC) in order to easily guide clinicians. Recent Findings UC is…”
Get full text
Journal Article -
2
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan
Published in British journal of clinical pharmacology (01-09-2015)“…Aims Triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan is a standard therapy for metastatic colorectal cancer (CRC). Single nucleotide…”
Get full text
Journal Article -
3
Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study
Published in Breast cancer research and treatment (01-09-2017)“…Background Taxanes are a mainstay in the treatment of metastatic breast cancer (mBC). Combination chemotherapy, including platinum–taxens doublets, can improve…”
Get full text
Journal Article -
4
Could Circulating Tumor Cells and ARV7 Detection Improve Clinical Decisions in Metastatic Castration-Resistant Prostate Cancer? The Istituto Nazionale dei Tumori (INT) Experience
Published in Cancers (13-07-2019)“…Enzalutamide and abiraterone have been shown to improve progression-free survival (PFS) and overall survival (OS) in metastatic castration-resistant prostate…”
Get full text
Journal Article -
5
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma
Published in Tumori (01-12-2021)“…Background: Cabozantinib strongly inhibits osteoclast differentiation and bone resorption in vitro. We aimed to evaluate its effect on bone turnover markers…”
Get full text
Journal Article -
6
Effects of cabozantinib on bone turnover markers in patients with metastatic renal cell carcinoma
Published in Journal of clinical oncology (20-02-2018)“…Abstract only 638 Background: In-vitro studies have shown that cabozantinib has a strong inhibitory action on osteoclast differentiation and bone-resorption…”
Get full text
Journal Article -
7
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients
Published in Oncotarget (07-03-2017)“…Predictive biomarkers of efficacy and toxicity of bevacizumab have not yet been validated. This study assessed the influence of IL-8, eNOS and VEGF-A…”
Get full text
Journal Article -
8
Safety and antitumor activity of weekly carboplatin plus paclitaxel in metastatic breast cancer: A ten years, single-institution, retrospective analysis
Published in Journal of clinical oncology (20-05-2017)“…Abstract only e12556 Background: Safety and activity of weekly carboplatin plus paclitaxel in patients (pts) with metastatic breast cancer (mBC) are poorly…”
Get full text
Journal Article